The CRLS1 gene helps your body make cardiolipin, a special fat that mitochondria need to produce energy and keep their inner structure stable. The protein made by this gene helps your cells support these energy centers, especially in organs that use a lot of fuel, such as the brain, muscles, and heart. If the CRLS1 gene does not work properly, mitochondria may not function well, and some people can develop a rare inherited mitochondrial condition with low energy, developmental delay, weakness, or heart problems. The CRLS1 gene is mainly known in medical genetics rather than popular culture.
What is a gene?
Genes are sections of DNA that carry instructions cells use to make molecules or regulate activities in the body. Some genes provide the code for proteins, which do much of the cell’s work. Others mainly direct when, where, and how much certain processes take place. In combination, genes affect how the body grows and works, and they can influence your response to food, stress, or medicines. For a deeper look at this topic, visit the LearnHub.
Overview
CRLS1Gene function
What if the gene works
The CRLS1 gene helps make cardiolipin, a fat that lines the inner membrane of mitochondria, your cells’ energy centers. This supports steady energy production and helps mitochondria keep their shape and work normally.
Risk
What if the gene does not work
More disruptive variants in the CRLS1 gene can cause a mitochondrial disease with developmental delay, low muscle tone, and growth or heart problems. Milder and more severe variants may affect when symptoms start and how strongly different organs are involved.
Treatment
What does that mean for your treatment
No CRLS1-specific treatment or drug selection approach is currently established for people with a pathogenic variant in the CRLS1 gene. Care is usually supportive and guided by the person’s symptoms rather than by the specific CRLS1 variant. The CRLS1 gene is being studied in mitochondrial lipid research, but this has not yet led to guideline-based therapies.
Gene function
What if the gene works
Your cells need healthy mitochondria to keep up with daily energy demands. Understanding what the CRLS1 gene does in the body helps explain how these energy-making structures work smoothly. It mainly supports the production of a key membrane fat that mitochondria use for stable, efficient function.
The CRLS1 gene helps your cells make cardiolipin, a special fat that lines the inner membrane of mitochondria. This membrane is the main workspace where cells prepare energy.
By supplying cardiolipin, this gene helps mitochondria organize the proteins that turn food and oxygen into ATP, the cell’s usable energy. That supports steady energy flow for everyday cell tasks.
Cardiolipin helps the inner mitochondrial membrane keep its shape and hold key protein groups in place. Through this role, the CRLS1 gene supports smooth, routine activity inside these energy-making parts of the cell.
What is a variant?
A genetic variant is a slight difference in the DNA sequence within a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not lead to any noticeable effect and simply represent natural genetic variation. At times, though, a variant can change how a gene works to a greater extent and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the CRLS1 gene can reduce or disrupt cardiolipin synthase, a protein that makes cardiolipin, a fat that helps hold the inner membrane of mitochondria together. In simple terms, how CRLS1 gene variants affect cells depends on how much they lower cardiolipin production, which can make energy-making protein groups less stable. Milder variants may leave some activity, while more severe variants can greatly reduce or nearly abolish it and are often linked to earlier or more pronounced mitochondrial disease.
How variants are linked to conditions
At present, the CRLS1 gene does not yet have a broadly confirmed link to a specific health condition, though research on CRLS1 gene variants linked to conditions is still developing. Anyone with a confirmed CRLS1-related diagnosis should rely on guidance from their doctor or genetic counselor rather than general information.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widely found in the general population. Most do not directly affect health and instead reflect natural human variation. For many genes, carrying a variant associated with a condition suggests a possible link rather than a confirmed diagnosis, especially when several genes and environmental influences play a role. In some situations, however, one well described variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the CRLS1 gene. For many living with a CRLS1 change, risk depends most on the exact variant and the health condition linked to it, rather than on clear lifestyle or environmental factors. Anyone concerned about personal or family risk should speak with a doctor or genetic counselor.
Inheritance of CRLS1 variants
CRLS1 gene variants linked to disease are inherited in an autosomal recessive pattern. This means a child usually inherits one altered copy of the CRLS1 gene from each parent, while the parents are typically carriers who do not have the condition themselves. When both parents carry a disease-causing variant, each pregnancy has a 25% chance of the child inheriting both altered copies, a 50% chance of being a carrier, and a 25% chance of inheriting two working copies. In practical terms, how CRLS1 variants are inherited often becomes clear only after the same variant is found on both sides of the family.
What does my CRLS1 result mean for my family?
For CRLS1, disease-causing changes are usually inherited in a recessive way, so close relatives are often healthy carriers without symptoms. Brothers and sisters may also carry the same change, and in some families a sibling could also have the condition. Parents and other adult relatives may want to learn whether they are carriers, especially when planning children.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the CRLS1 gene, genetic testing uses a blood or saliva sample to read the gene’s DNA code. This is how to find out about CRLS1 gene variants, and the result may show a variant is present, absent, or of uncertain significance.
When should I consider getting a genetic test?
Consider testing for changes in the CRLS1 gene if a baby or child has signs of a rare inherited condition affecting energy production, such as severe muscle weakness, developmental problems, seizures, or heart or liver problems without a cause. Testing can also help when there is a family history of a CRLS1-related condition or similar unexplained illness, especially in siblings.
A genetic result is only one part of your health story
A genetic finding can provide useful information, but how much it reveals depends on the condition and on the kind of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body functions. For some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas such as medication response, it can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same medication may work well for one person, have less effect in another, or cause more side effects in someone else. Part of the reason is that inherited differences can change how the body absorbs, breaks down, transports, or responds to a drug, and these differences are common.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can shape a person’s response to medication. It focuses on patterns between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body processes it. This information can support more informed, more individualized treatment decisions. You can read more about this topic in the LearnHub.
Drugs influenced by the CRLS1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or medication response. Questions about side effects, changing medicines, or other health concerns are best discussed with your doctor or pharmacist.
History
The CRLS1 gene entered the genetics literature as researchers worked to identify the human genes involved in making cardiolipin, a lipid first recognized in heart tissue decades earlier. Initially understood through cell and biochemistry studies, it was later linked to a specific gene as gene mapping and DNA sequencing improved. From these first observations, research expanded steadily. Work on CRLS1 became part of a broader effort to understand how mitochondria, the cell’s energy producing structures, build and maintain their membranes. Over time, descriptions became more precise as scientists connected laboratory findings with rare inherited conditions. This history is mainly scientific rather than public, with CRLS1 known mostly through research and clinical genetics rather than media attention.